Lennar Price Target, Predictions & Analyst Ratings

-1.32 (-1.24 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume2.04 million shs
Average Volume2.01 million shs
Market Capitalization$32.95 billion
P/E Ratio9.75
Dividend Yield0.95%

Lennar (NYSE:LEN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
19 Wall Street analysts have issued ratings and price targets for Lennar in the last 12 months. Their average twelve-month price target is $108.06, predicting that the stock has a possible upside of 2.77%. The high price target for LEN is $160.00 and the low price target for LEN is $77.00. There are currently 8 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
TypeToday30 Days Ago90 Days Ago180 Days Ago
LEN Consensus Rating: BuyBuyBuyBuy
LEN Consensus Rating Score: 2.582.582.502.55
LEN Analyst Ratings: 0 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
LEN Consensus Price Target: $108.06$108.06$96.33$86.11
LEN Price Target Upside: 2.77% upside22.88% upside14.53% upside20.57% upside

Lennar (NYSE:LEN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Lennar (NYSE:LEN) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetDetails
7/19/2021Seaport Res Ptn
M. Weintraub
Reiterated RatingNeutral
6/18/2021Evercore ISI
Boost Price TargetOutperform$121.00 ➝ $160.00
6/18/2021BTIG Research
Boost Price TargetPositive ➝ Buy$117.00 ➝ $127.00
6/18/2021JMP Securities
Boost Price TargetMarket Outperform$120.00 ➝ $130.00
6/18/2021Royal Bank of Canada
Boost Price TargetAverage ➝ Sector Perform$97.00 ➝ $100.00
Boost Price TargetEqual Weight$105.00 ➝ $110.00
6/18/2021JPMorgan Chase & Co.
UpgradeNeutral ➝ Overweight$115.00 ➝ $141.00
J. Mccanless
Reiterated RatingOutperform
4/21/2021Wells Fargo & Company
Initiated CoverageEqual Weight$112.00
3/18/2021Raymond James
Boost Price TargetOutperform$90.00 ➝ $105.00
3/18/2021Credit Suisse Group
Boost Price TargetNeutral$90.00 ➝ $107.00
3/16/2021Wolfe Research
Initiated CoverageOutperform
12/21/2020Smith Barney Citigroup
Boost Price Target$90.00 ➝ $100.00
Boost Price TargetBuy$88.00 ➝ $100.00
12/18/2020Bank of America
Boost Price Target$87.00 ➝ $97.00
12/17/2020Keefe, Bruyette & Woods
Boost Price TargetOutperform$95.00 ➝ $98.00
12/8/2020UBS Group
Initiated CoverageNeutral$77.00
11/2/2020Atlantic Securities
Initiated CoverageOverweight$93.00
10/26/2020Zelman & Associates
DowngradeBuy ➝ Hold
9/17/2020Susquehanna Bancshares
Jack Micenko
UpgradeNeutral ➝ Positive$77.00 ➝ $94.00
7/13/2020Seaport Global Securities
M. Weintraub
DowngradeBuy ➝ Neutral
Anthony Pettinari
Boost Price TargetPositive ➝ Buy$53.00 ➝ $76.00
Boost Price TargetHold$40.00 ➝ $56.00
4/2/2020The Goldman Sachs Group
DowngradeBuy ➝ Neutral$48.00 ➝ $47.00
10/3/2019Buckingham Research
Boost Price TargetBuy$60.00 ➝ $67.00
8/12/2019SunTrust Banks
Initiated CoverageHold ➝ Hold$47.00
Boost Price TargetOverweight ➝ Overweight$50.00 ➝ $57.00
1/10/2019Deutsche Bank Aktiengesellschaft
Boost Price TargetBuy$56.00
Haendel St. Juste
Set Price TargetBuy$60.00
10/4/2018MKM Partners
Megan McGrath
Set Price TargetBuy$61.00
(Data available from 8/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.